This year’s crop of winning products features many with a clinical focus and others that represent significant advances in sequencing, single-cell analysis, and more.
Studies The Scientist covered this year illustrate the expanding importance of genetic and genomic research in all aspects of life science, from ecology to medicine.
Clinical trials that target human endogenous retroviruses to treat multiple sclerosis, ALS, and other ailments are underway, but many questions remain about how these sequences may disrupt our biology.
Rashmi Shivni, Drug Discovery News | May 20, 2023 | 10 min read
George Church is at it again, this time using multiplex gene editing to create virus-proof cells, improve organ transplant success, and protect elephants.
The "war on drugs" will not be won in the jungles of Colombia or along the borders of the United States. Drug abuse will come under control when we, as scientists, find ways to relieve addicts of their compulsive need for a fix. Addictions are chronic diseases originating in adolescence and young adulthood. Although the decision to experiment with drugs may have been voluntary, what occurs thereafter is a physiological disorder, not a "failure of will." Susceptibility to addiction is an inhere
An open mind and collaborative spirit have taken Hans Clevers on a journey from medicine to developmental biology, gastroenterology, cancer, and stem cells.